Discussions about diagnostics ran through SurfingNASH’s entire coverage of the Fourth Global NASH Congress. Listen here for some of the diagnostics highlights. The group discusses exciting new precision diagnostics, urine and breath-based biopsies, realistic expectations for diagnostics in market today and implications for clinical trials and patient treatment and other related questions in a fast-moving set of pieces.
TOPICS: AASLD, cirrhosis, Diagnostic Tests, DrugTrial, EchoSens, Elastography, ELF, Fatty Liver, FIB-4, FibroScan, Fibrosis Level 3, Fibrosis Level 4, Genfit, Gilead Sciences, MRI-PDFF, NAFLD, NASH, non-invasive liver testing, Nordic Biosciences, Phase3, Siemens Healthineers, Tawazun Health, TrialDesign,
Surfing The NASH Tsunami is brought to you by HEP Dynamics
#HEPdynamics #SurfingNASH #podcast